Literature DB >> 3023078

Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli.

P Wingfield, M Payton, J Tavernier, M Barnes, A Shaw, K Rose, M G Simona, S Demczuk, K Williamson, J M Dayer.   

Abstract

The high-level expression of human interleukin-1 beta in Escherichia coli is described. The protein contributes about 12% of the total cell protein and is associated with the soluble cytoplasmic fraction of the cell. A method for the purification of the protein is given which is based on anion- and cation-exchange chromatographies. The isolated protein, shown to be homogeneous by several analytical methods, has been characterized by amino acid analysis, N- and C-terminal sequence analysis and analytical centrifugation. The protein is biologically active as demonstrated by two different in vitro assays, namely, the mononuclear cell factor (IL-1/MCF) assay and lymphocyte activating factor (IL-1/LAF) assay. The specific activities determined with the IL-1/MCF and IL-1/LAF assays, are 2 X 10(7) and 4 X 10(7) units mg-1, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023078     DOI: 10.1111/j.1432-1033.1986.tb10066.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  33 in total

Review 1.  Preparation of Soluble Proteins from Escherichia coli.

Authors:  Paul T Wingfield
Journal:  Curr Protoc Protein Sci       Date:  2014-11-03

2.  Determination of solvent content in cavities in IL-1beta using experimentally phased electron density.

Authors:  Michael L Quillin; Paul T Wingfield; Brian W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

3.  Role of TNF and IL-1 in infections with Toxoplasma gondii.

Authors:  H R Chang; G E Grau; J C Pechère
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Isolation and bioactivities of three IL-1 beta N-terminal variants.

Authors:  K A Richard; A W Yem; M R Deibel; N D Staite
Journal:  Agents Actions       Date:  1989-06

6.  Stereospecific assignment of beta-methylene protons in larger proteins using 3D 15N-separated Hartmann-Hahn and 13C-separated rotating frame Overhauser spectroscopy.

Authors:  G M Clore; A Bax; A M Gronenborn
Journal:  J Biomol NMR       Date:  1991-05       Impact factor: 2.835

7.  Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF).

Authors:  P Wingfield; R Benedict; G Turcatti; B Allet; J J Mermod; J DeLamarter; M G Simona; K Rose
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

8.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction.

Authors:  F Shirakawa; K Saito; C A Bonagura; D L Galson; M J Fenton; A C Webb; P E Auron
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.